医師紹介

このページを印刷

山口 徹雄

カテーテルとやさしさで、心臓も、あなたの心も癒します

山口 徹雄YAMAGUCHI TETSUO

循環器センター内科 医長、心臓・血管カテーテルセンター 副センター長
平成18年卒

循環器センター内科心臓・血管カテーテルセンター

メッセージ

循環器センターを受診されるすべての方に安全で最新・最良の医療を提供できるよう努力して参ります。

専門・実績

2006年に神戸大学を卒業後、心臓カテーテル治療で有名な大阪府済生会中津病院でトレーニング。2008年より虎の門病院で総合内科および循環器内科のさらなるトレーニングを行った後、2011年より武蔵野赤十字病院で主に冠動脈疾患のカテーテル治療(PCI)や末梢動脈疾患のカテーテル治療(EVT)に従事してきました。主術者としてPCIは500例以上、EVTは300例以上の治療経験があります。
2017年に東京医科歯科大学大学院を卒業、医学博士を取得。
2019年7月より虎の門病院循環器センター内科医長・心臓・血管カテーテルセンター 副センター長として赴任しました。
赴任後PCIやEVTに加え、新しく始まった経カテーテル大動脈弁植え込み術(TAVI)チームの術者として経験を積みました。更なる経験を求めて2022年3月からカナダ・トロント大学に留学しました。留学中にTAVIを約600例(主術者として400例・副術者として200例)に加え、経皮的僧帽弁接合不全修復術(Mitraclip)を主術者として約80例、経皮的左心耳閉鎖術(Watchman)を主術者として約50例経験しました(グローバルの資格を取得 リンク1)。また、日本未導入の新しいTAVI弁(ACURATE弁・グローバルの植え込み資格保有 リンク2)や脳梗塞予防デバイス(Sentinel, 100例以上の経験)、経皮的三尖弁接合不全修復術(Triclip, 主術者として30例以上の経験)等の経験も積んできました。これら最新の治療経験を虎の門病院の患者さんにいち早く・安全に提供したいと考えています。

認定資格

日本循環器学会 循環器専門医
日本内科学会 総合内科専門医
日本心血管インターベンション治療学会(CVIT)専門医
経カテーテル的心臓弁治療関連学会協議会認定TAVR実施医(Sapienシリーズ)
経皮的左心耳閉鎖術(Watchmanデバイス)グローバル資格(リンク1)
ACURATE NEO2 TAVI弁グローバルインプランター資格(リンク2)
トロント大学Clinical Fellow修了

所属学会

日本循環器学会
日本内科学会
日本心血管インターベンション治療学会
日本心臓病学会
日本心不全学会

主な経歴

  1. 神戸大学医学部医学科卒業

  2. 大阪府済生会中津病院・虎の門病院・武蔵野赤十字病院でトレーニング

  3. 東京医科歯科大学大学院循環制御内科学講座卒業・医学博士を取得

  4. 虎の門病院循環器センター内科医長兼心臓血管カテーテルセンター副センター長

  5. Clinical Fellow of Structural Heart Intervention, University of Toronto, Sunnybrook Health Science Center

  6. 虎の門病院循環器センター内科医長兼心臓血管カテーテルセンター副センター長として帰国、勤務

主要著書・出版

【新聞等のインタビュー記事】
1. 高血圧の放置がリスク 心臓弁膜症、自覚しにくく 
  2021年12月10日 日本経済新聞
2. 隠れ心不全 症状が出る前に気づき、悪化を防ぐには?
  2022年8月26日 日本経済新聞
3. 仮面高血圧に注意 就寝時など急上昇、健診では分からず
  2022年10月21日 日本経済新聞
4. 心肺蘇生講習者の増加に従い実施率と予後が改善
  2023年9月12日 日経メディカルオンライン



【英文原著論文】
1. Tao S, Yamauchi Y, Maeda S, Okada H, Yamaguchi T, Hara N, Konishi Y, Umemoto T, Miyamoto T, Obayashi T, Hirao K, Isobe M. Adenosine triphosphate-induced atrial fibrillation: the clinical significance and relevance to spontaneous atrial fibrillation.
J Interv Card Electrophysiol (2014) 39:103–109

2. Yamaguchi T, Miyamoto T, Yamauchi Y, Obayashi T. Congenital left ventricular aneurysm.
Circ J.2015; 79:668-669

3. Yamaguchi T, Miyamoto T, Iwai T, et al. Prognosis of super-elderly healthy Japanese patients after pacemaker implantation for bradycardia.
J Cardiol 2017; 70:18-22.

4. Yamaguchi T, Yoshikawa T, Isogai T, Miyamoto T, Maekawa Y, Ueda T, Sakata K, Murakami T, Yamamoto T, Nagao K, Takayama M. Predictive Value of QRS Duration at Admission for In-Hospital Clinical Outcome of Takotsubo Cardiomyopathy.
Circ J 2017; 81: 62–68

5. Matsue Y, Damman K, Voors A, Kagiyama N, Yamaguchi T, Okumura T, et al. Time-to-Furosemide Treatment and Mortality in Patients Hospitalized with Acute Heart Failure.
J Am Coll Cardiol 2017; 69:3042-51.

6. Iwata Y, Ueshima D, Jujo K, Kaneko N, Umemoto T, Utsunomiya M, Doijiri T, Murata T, Miyazaki T, Yamaguchi T, Kobayashi Y. Crossover stenting across the deep femoral artery: a multicenter retrospective study.
Cardiovasc Interv Ther 2018; 33: 372-378.

7. Hara N, Miyamoto T, Iwai T, Yamaguchi J, Hijikata S, Watanabe K, Sagawa Y, Masuda R, Miyazaki R, Miwa N, Sekigawa M, Yamaguchi T, Nagata Y, Nozato T, Obayashi T. Assessment of the Safety and Efficacy of Edoxaban for the Treatment of Venous Thromboembolism Secondary to Active Malignancy.
Ann Vasc Dis.2017; 10:407-410.

8. Yamaguchi T, Kitai T, Miyamoto T, Kagiyama N, Okumura T, Kida K, et al. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized with Heart Failure with Reduced Ejection Fraction.
Am J Cardiol 2018; 121:969–974.

9. Isogai T, Yoshikawa T, Ueda T, Yamaguchi T, Imori Y, Maekawa Y, Sakata K, Murakami T, Mochizuki H, Arao K, Kimura A, Nagao K, Yamamoto T, Takayama M. Apical Takotsubo syndrome versus anterior acute myocardial infarction: findings from the Tokyo Cardiovascular Care Unit network registry.
Eur Heart J Acute Cardiovasc Care. 2019; 8: 86-95.

10. Higashitani M, Uemura Y, Mizuno A, Utsunomiya M, Yamaguchi T, Matsui A, et al. Cardiovascular Outcome and Mortality in Patients Undergoing Endovascular Treatment for Symptomatic Peripheral Artery Disease ― Short-Term Results of the Toma-Code Registry ―.
Circ J 2018; 82: 1917–1925.

11. Sagawa Y, Nagata Y, Yamaguchi T, et al. Comparison of direct oral anticoagulants and warfarin regarding midterm adverse events in patients with atrial fibrillation undergoing catheter ablation.
J Arrhythmia 2018; 34:428-434.

12. Yamaguchi T, Miyamoto T, Sekigawa M, Watanabe K, Hijikata S, Yamaguchi J, Iwai T, Sagawa Y, Miyazaki R, Masuda R, Miwa N, Hara N, Nagata Y, Obayashi T, Nozato T. Early Transfer of Patients with Acute Heart Failure from a Core Hospital to Collaborating Hospitals and Their Prognoses.
Int Heart J 2018; 59: 1026-1033.

13. Isogai T, Yoshikawa T, Yamaguchi T, Arao K, Ueda T, Imori Y, Maekawa Y, Murakami T, Yamamoto T, Nagao K, Takayama M. Differences in Initial Electrocardiographic Findings of Apical Takotsubo Syndrome According to the Time from Symptom Onset.
Am J Cardiol 2018;122:1630−1637.

14. Kondo T, Okumura T, Matsue Y, Shiraishi A, Kagiyama N, Yamaguchi T, et al. Specialty-Related Differences in the Acute-Phase Treatment and Prognosis in Patients With Acute Heart Failure - Insights From REALITY-AHF.
Circ J 2019; 83: 174–181.

15. Miwa N, Nagata Y, Yamaguchi T (Corresponding Author), Nagase M, Sasaki T, Nozato T, AshikagaT, Goya M, Hirao K. Impact of diurnal variations in the QRS complex and T-waves on the eligibility of subcutaneous implantable cardioverter-defibrillators.
Heart Rhythm 2019;16:913–920.

16. Yamaguchi T, Nakai M, Sumita Y, Nishimura K, Miyamoto T, Sakata Y et al. The impact of institutional case volume on the prognosis of ruptured aortic aneurysms: a Japanese nationwide study.
Interact CardioVasc Thorac Surg 2019; 29:109-116.

17. Yamaguchi T, Nakai M, Sumita Y, Nishimura K, Tazaki J, Kyuragi R, et al. Endovascular repair versus surgical repair for Japanese patients with ruptured thoracic and abdominal aortic aneurysms: a nationwide study performed in Japan.
Eur J Vasc Endovasc Surg 2019;57:779-786.

18. Yamaguchi T, Nozato T, Miwa N, Sagawa Y, Watanabe K, Nagata Y, et al. Impact of the preprocedural nutrition status on the clinical outcomes of patients after pacemaker implantation for bradycardia.
J Cardiol 2019;74: 284-289.

19. Kagiyama N, Kitai T, Hayashida A, Yamaguchi T, Okumura T, Kida K, et al. Prognostic Value of BNP Reduction During Hospitalization in Patients With Acute Heart Failure.
J Cardiac Fail 2019; 25:712-721.

20. Yoshioka K, Matsue Y, Yamaguchi T, Kitai T, Kagiyama N, Okumura T, et al. Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure.
Am J Cardiovasc Drugs 2019; 19: 597–605.

21. Yamaguchi T, Nakai M, Sumita Y, Nishimura K, Nagai T, Anzai T, et al. Impact of Endovascular Repair on the Outcomes of Octogenarians with Ruptured Abdominal Aortic Aneurysms: A Nationwide Japanese Study.
Eur J Vasc Endovasc Surg 2020; 59:219-225.

22. Kimura A, Yoshikawa T, Isogai T, Tanaka H, Ueda T, Yamaguchi T, et al. Impact of body temperature at admission on inhospital outcomes in patients with takotsubo syndrome: insights from the Tokyo Cardiovascular Care Unit Network Registry.
Eur Heart J Acute Cardiovasc Care. 2020; 9: 703-710.

23. Yamaguchi T, Nakai M, Sumita Y, Nishimura K, Nozato T, Ashikaga T, et al. Sex differences in Japanese patients with ruptured aortic aneurysms.
J Vasc Surg 2020; 71:1907-1912.

24. Yamaguchi T, Nakai M, Sumita Y, Miyamoto Y, Matsuda H, Inoue Y, Yoshino H, Okita Y, Minatoya K, Ueda Y, Ogino H. Current status of the management and outcomes of acute aortic dissection in Japan: Analyses of nationwide Japanese Registry of All Cardiac and Vascular Diseases-Diagnostic Procedure Combination data.
Eur Heart J Acute Cardiovasc Care 2020 ;9: S21-S31.

25. Aihara H, Higashitani M, Takimura H, Tobita K, Jujo K, Hozawa K, Yamaguchi T, Iwata Y, Tokuyama H, Sakurai M, Murata N, Fujimoto Y, Kikuchi A, Koganei H, Sato A, Noguchi Y, Ieda M. Differences in Intravascular Ultrasound Measurement Values Between Treatment Modalities for Restenosis in Femoropopliteal Lesions.
Circ J 2020 ;84 :1320-1329.

26. Hayasaka K, Matsue Y, Kitai T, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Mizukami A, Yoshioka K, Kuroda S, Kagiyama N, Yamaguchi T, Sasano T. Tricuspid regurgitation pressure gradient identifies prognostically relevant worsening renal function in acute heart failure.
Eur Heart J Cardiovasc Imaging. 2020 Mar 11:jeaa035. doi: 10.1093/ehjci/jeaa035. Epub ahead of print. PMID: 32157273.

27. Yoshioka K, Matsue Y, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Mizukami A, Kuroda S, Kagiyama N, Yamaguchi T, Sasano T, Matsumura A, Kitai T. Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure.
PLoS One. 2020 Jun 26;15: e0235493.

28. Yamaguchi T, Nakai M, Sumita Y, et al. Impact of structural and process quality indicators on the outcomes of acute aortic dissection.
Eur J Cardiothorac Surg. 2020; 58: 1281-1288.

29. Sagawa Y, Nagata Y, Yamaguchi T (Corresponding Author), et al. Long-Term Performance of Right Ventricular Implantable Cardioverter-Defibrillator Leads in Arrhythmogenic Right Ventricular Cardiomyopathy and Hypertrophic Cardiomyopathy.
Int Heart J 2020 Jan 31;61(1):39-45.

30. Yamaguchi T, Ueshima D, Utsunomiya M, et al. Optimal cut-off value of preprocedural geriatric nutritional risk index for predicting the clinical outcomes of patients undergoing endovascular revascularization for peripheral artery disease.
J Cardiol 2021; 77:109-115.

31. Ochiai Y, Yamaguchi T (Corresponding Author), Komiyama C, Kodama T. Impact of Anticoagulation Therapy on the Risk of Pulmonary Embolism and Bleeding Events in Patients with Isolated Distal Deep-Vein Thrombosis.
Int Heart J 2021; 62:601-606.

32. Yamaguchi T, Nakai M, Yano T, Matsuyama M, Yoshino H, Miyamoto Y, Sumita Y, Matsuda H, Inoue Y, Okita Y, Minatoya K, Ueda Y, Ogino H. Population-based incidence and outcomes of acute aortic dissection in Japan.
Eur Heart J Acute Cardiovasc Care. 2021; 10:701-709.

33. Kida K, Kitai T, Suzuki N, Ashikaga K, Kou S, Kagiyama N, Yamaguchi T, Okumura T, Mizuno A, Oishi S, Inuzuka Y, Akiyama E, Suzuki S, Yamamoto M, Matsue Y. Prognostic Implications of Reductions in Heart Rates in Patients With Acute Heart Failure and Atrial Fibrillation.
Circ J 2021; 85:1869-1875.

34. Imori Y, Yamaguchi T, et al. Ethnic comparison in takotsubo syndrome: novel insights from the International Takotsubo Registry.
Clin Res Cardiol 2022; 111:186-196.

35. Saito T, Yamaguchi T (Corresponding Author), Kuroda S, et al. Impact of Body Mass Index on the Outcome of Japanese Patients with Cardiovascular Diseases and/or Risk Factors Hospitalized with COVID-19 Infection.
J Cardiol 2022; 79:476-481.

36. Yoshioka K, Maeda D, Okumura T, Kida K, Oishi S, Akiyama E, Suzuki S, Yamamoto M, Mizukami A, Kuroda S, Kagiyama N, Yamaguchi T, Sasano T, Matsumura A, Kitai T, Matsue Y. Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure.
Sci Rep 2022; 12:2127.

37. Yamauchi Y, Takahara M, Iida O, Shintani Y, Sugano T, Yamamoto Y, Kawasaki D, Fujihara M, Soga Y, Hirano K, Yamaguchi T, Yokoi H, Miyamoto A, Nakamura M; OMOTENASHI investigators. Independent predictors of major adverse cardiovascular events at 3 years after aortoiliac stent implantation.
J Vasc Interv Radiol 2022; 33:826-833.

38. Shibahashi E, Jujo K, Kuroda S, Matsumoto S, Sano T, Kitai T, Yonetsu T, Kohsaka S, Torii S, Yamaguchi T, Kishi T, Komuro I, Hirata K, Node K, Matsue Y. Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry.
Thromb Res. 2022; 216:90-96.

39. Taishi Dotare, Daichi Maeda, Yuya Matsue, Tsutomu Sunayama, Keisuke Kida, Takeshi Kitai, Nobuyuki Kagiyama, Tetsuo Yamaguchi, Takahiro Okumura, Atsushi Mizuno, Shogo Oishi, Yasutaka Inuzuka, Eiichi Akiyama, Satoshi Suzuki, Masayoshi Yamamoto, Tohru Minamino. Early drop in systolic blood pressure is associated with poor diuretic response and prognosis in patients with acute heart failure.
Eur Heart J Acute Cardiovasc Care 2022; 11:749-757.

40. Hijikata S, Yamaguchi T (Corresponding Author), Ueshima D, Umemoto T, Mizuno A, Matsui A, Kaneko N, Ozaki S, Doijiri T, Jujo K, Kodama T, Higashitani M. Prognostic impact of atrial fibrillation on the outcomes of peripheral artery disease according to preoperative symptoms for endovascular revascularization.
Heart Vessels 2023; 38:106-113.

41. Komatsu Y, Higashitani M, Ueshima D, Mizuno A, Yamaguchi T, Kodama T, Tanaka T, Jujo K, Murata N, Ookoshi S, Ochiai T, Taya Y, Nemoto Y, Abe N, Anzai H, Chikamori T. Comparison of the incidence of depression before and after endovascular treatment in patients with lower limb peripheral artery disease.
Heart Vessels 2023; 38:164-170.

42. Iwai, T., Yamaguchi T (Corresponding Author)., Ueshima, D. et al. Differences in major limb outcomes by indication for lower extremity endovascular revascularization in patients receiving hemodialysis.
Heart Vessels 2023; 38:488-496.

43. Arao K, Yoshikawa T, Isogai T, Imori Y, Mochizuki H, Sakata K, Takaoka Y, Yamaguchi T, Nagao K, Yamamoto T, Takayama M. A study of takotsubo syndrome over 9 years at the Tokyo Cardiovascular Care Unit Network Registry.
J Cardiol 2023; 82:93-99.

その他

東京都CCUネットワーク たこつぼ心筋症研究班員

PAGE TOP